LIANBIO's ticker is and the CUSIP is 53000N108. A total of 37 filers reported holding LIANBIO in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,310,618 | -34.6% | 3,564,173 | 0.0% | 0.02% | -33.3% |
Q2 2023 | $8,126,314 | +16.9% | 3,564,173 | 0.0% | 0.03% | 0.0% |
Q1 2023 | $6,950,137 | +18.9% | 3,564,173 | 0.0% | 0.03% | +13.8% |
Q4 2022 | $5,845,244 | -17.6% | 3,564,173 | 0.0% | 0.03% | -12.1% |
Q3 2022 | $7,093,000 | -7.9% | 3,564,173 | 0.0% | 0.03% | -5.7% |
Q2 2022 | $7,699,000 | +38.3% | 3,564,173 | +137.6% | 0.04% | +59.1% |
Q1 2022 | $5,565,000 | -39.8% | 1,500,000 | 0.0% | 0.02% | -18.5% |
Q4 2021 | $9,240,000 | – | 1,500,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,282,084 | $4,929,000 | 4.16% |
Perceptive Advisors | 56,560,211 | $122,170,000 | 3.83% |
SCHF (GPE), LLC | 937,500 | $2,025,000 | 2.99% |
VR Adviser, LLC | 5,378,341 | $11,617,000 | 2.29% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,314,173 | $7,159,000 | 0.52% |
Affinity Asset Advisors, LLC | 450,000 | $972,000 | 0.41% |
Altium Capital Management LP | 315,191 | $681,000 | 0.27% |
RA Capital Management | 4,622,574 | $9,985,000 | 0.27% |
22NW, LP | 141,223 | $305,000 | 0.16% |
Logos Global Management LP | 394,486 | $852,000 | 0.16% |